VeraSTAT-Sports Performance

Home - VeraSTAT

VeraSTAT-Sports Performance

Best in the Field

  • null

    Eliminate delays in sending samples to labs and receive rapid results for rapid recovery in 6 minutes.

  • null

    Requires just a few drops of whole blood or serum, ideal for use at the point of care.

  • null

    Lightweight, portable and convenient, the Randox VeraSTAT delivers diagnostic results where and when they are required.

  • null

    The Randox VeraSTAT allows for results to be exported via bluetooth connectivity.

  • null

    Intuitive user interface guides the operator through the entire testing process.

VeraSTAT-Improve your performance

As the best it’s field, the Randox VeraSTAT device allows athletes to overcome the limitations of other generation tests, providing accurate, cost effective and reliable results that will help users receive the care necessary to get them back on their feet and back to their best.

Monitoring response to exercise is vitally important to an athlete and trainer. While a heavy training schedule can lead to chronic immunosuppression in athletes, it is essential that they receive the appropriate care in the case of a dip in health state. Eliminating the risk of inflammation and infection is essential to preventing disruptions to practice and performance.

GET IN TOUCH

VeraSTAT Test Menu

The VeraSTAT testing menu is designed to monitor an athletes immune response to exercise. C-Reactive Protein (CRP) levels are used to guide the treatment of bacterial infections or inflammation associated with tissue injury and other inflammatory disorders. On the other hand, Mxyovirus Resistance Protein 1 (MxA) is used as a key indicator of viral infections. These tests used in combination, can allow healthcare clinicians to determine the best course of treatment and get the athlete back to full health

C-Reactive Protein (CRP)

CRP is a Key indicator of inflammation and stress, often resulting from the breakdown in tissues. Overtraining can lead to elevated levels of CRP in the body.

 

Myxovirus Resistance Protein I (MxA)

MxA is a key indicator of a viral infection which may impact physical performance and activity levels. Unexplained failures are often attributed to recent or current infections.

Glycated Hemoglobin (HbA1c)

*In Development

For the quantitative determination of Hemoglobin A1c in whole blood samples

COMING SOON

Creatine Kinase MB (CKMB)

* In Development

For the quantitative measurement of CK-MB in whole blood samples to assist diagnosis of an acute myocardial infarction

COMING SOON

Identification and Differentiation of Viral and Bacterial Respiratory Infection to Guide Antibiotic Stewardship

https://www.linkedin.com/company/107191

Identification and Differentiation of Viral and Bacterial Respiratory Infection to Guide Antibiotic Stewardship

 

The development of point-of-care testing is critical in the identification and differentiation between bacterial and viral respiratory infections. Defining the indications of infection to improve antibiotic stewardship, ensures that patients are protected from unnecessary antibiotic use and antibiotic resistance. It has been shown that particular protein biomarkers, such as myxovirus resistance protein (MxA) and C-reactive protein (CRP), differentiate infections between bacterial and viral. Using point-of-care platforms, such as Randox’s VeraSTAT, for detection of these protein biomarkers may provide more rapid and cost-effective discriminating tools.

The treatment of bacterial and viral infections can differ significantly, however people are often treated with empirical antibiotics due to a lack of paid and accurate testing. Although early intervention of infection is urgent, current diagnostic methods are either time intensive or inaccurate. The challenges clinicians are faced with in the differentiation of viral or bacterial respiratory infection can lead to delayed diagnosis, misappropriation of antibiotics and increased healthcare costs.

MxA protein has the potential to greatly enhance the rapid detection of viral respiratory infections as it increases significantly when there is actuate viral infection. CRP is the dominant acute phase protein often used to guide treatment of a bacterial infection or inflammation associated with tissue injury, inflammatory disorders, and associated diseases.

CRP & MxA together, allow clinicians to make appropriate decisions in supporting antimicrobial stewardship and guide the appropriate use of antibiotics, saving time performing unnecessary tests, providing unnecessary treatment which missing the opportunity to provide the right treatment in a timely manner.

The Randox VeraSTAT is a simple, accurate, portable point of care device which delivers rapid results via the use of patented cathodic electrochemiluminescence technology (C-ECL). Designed with the aim of offering users the next generation of rapid diagnosis, the VeraSTAT eliminates the requirement to send samples to a laboratory and instead returns results in as little as 6 minutes.

 

  • Eliminates delays in sending samples to the lab and facilitate immediate decision making at the point of care.
  • Lightweight, portable and convenient, the Randox VeraSTAT can be used in a variety of locations to deliver results as required, such as a GP surgery or Emergency Department.
  • Intuitive user interface guides the operator through the entire testing process.
  • All necessary reagents are conveniently included in each single use, sealed cassette with no preparation required. All necessary consumables are supplied with the kit.
  • The Randox VeraSTAT allows for results to be exported via Bluetooth connectivity.
  • Flexible test menu comprising of a range of immunoassay, protein, inflammatory, diabetes & infectious disease markers.

 

Novel testing approaches identifying the type of infection at the point of care are essential in accurately guiding appropriate antibiotic treatment. Although these tests can’t determine what type of viral or bacterial infection a patient has, it will determine whether the infection is viral or bacterial, further testing is then carried out to determine what type of pathogen the patient has via PCR – the gold standard. The ability to distinguish between viral and bacterial infections is the most effective guide for clinical decision making and is an innovative tool for antibiotic stewardship.

 

References

1 – Fleming-Dutra K.E., Hersh A.L., Shapiro D.J. Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010–2011. JAMA. 2016;315:1864–1873. doi: 10.1001/jama.2016.4151.

2 – Cals JW, Hopstaken RM, Butler CC, Hood K, Severens JL, Dinant GJ. Improving management of patients with acute cough by C-reactive protein point of care testing and communication training (IMPAC3T): study protocol of a cluster randomised controlled trial. BMC Fam Pract. 2007;8:15.

3- New report calls for urgent action to avert antimicrobial resistance crisis [Internet]. World Health Organization. World Health Organization; 2019

4 – Hutchings MI, Truman AW, Wilkinson B. Antibiotics: past, present and future. Curr Opin Microbiol. (2019) 51:72–80. doi: 10.1016/j.mib.2019.10.008

 

For more enquiries please contact the Marketing team: market@randox.com

ABOUT RANDOX

NEWS

VACANCIES

OUR PEOPLE


CRP & MxA VeraSTAT

VeraSTAT | CRP & MxA 

Rapid Differentiation of Viral & Bacterial Respiratory Infections

MxA protein has the potential to greatly enhance the rapid detection of viral respiratory infections and increases significantly when there is actuate viral infection.
CRP is the dominant acute phase protein often used to guide treatment of a bacterial infection or inflammation associated with tissue injury, inflammatory disorders, and associated diseases.

Together, allow clinicians to make appropriate decision in supporting antimicrobial stewardship and guide thappropriate use of antibiotics.

MxA

VeraSTAT MxA kit is an in vitro near-patient diagnostic test for the quantitative determination of Myxovirus resistance protein A (MxA) from whole blood.  The MxA Kit is used for detection of acute respiratory tract viral infections from symptomatic patients.

CRP

VeraSTAT CRP kit is an in vitro near-patient diagnostic test for the quantitative determination of C-reactive protein (CRP) from whole blood to assess the inflammatory status of the body.

Sample Volume- 7 μL

Sample Type- Whole Blood

Measuring Time- 11 minutes

Ordering Information: VS1004

Sample Volume- 5 μL

Sample Type- Whole Blood

Measuring Time- 6 minutes 

Ordering Information: VS1003

Enquire Now

MxA Test- Training Video

CRP Test- Training Video

Useful Resources

VERASTAT-V

GET IN TOUCH

VERASTAT BROCHURE


VeraSTAT

 

 

 

 

VeraSTAT | Excellence at the Point of Care

Accurate & Reliable Results in Minutes

Why Choose the VeraSTAT?

  • null
    Eliminate delays in sending samples to the lab and facilitate immediate decision making at the point of care.

     

  • null
    All necessary reagents are conveniently included in each single use, sealed cassette with no preparation required. All necessary consumables are supplied with the kit.

     

  • null
    Lightweight, portable and convenient, the Randox VeraSTAT can be used in a variety of locations to deliver results as required.

     

  • null
    The Randox VeraSTAT allows for results to be exported via bluetooth connectivity.
  • null
    Intuitive user interface guides the operator through the entire testing process.

     

  • null
    Flexible test menu comprising of a range of immunoassay, protein, inflammatory, diabetes & infectious disease markers.

The Randox VeraSTAT is a simple, accurate, portable point of care device which delivers rapid results via the use of patented cathodic electrochemiluminescence technology (C-ECL).

Through this technology, the target analyte in the patient sample reacts with the labelled antibody and captured antibody. After the reaction, unbound or excess labelled antibody is washed away and the labelled antibody complex is excited with electricity, with the electrochemiuminescence being measured and an accurate result produced.

Designed with the aim of offering users the next generation of rapid diagnosis, the VeraSTAT eliminates the requirement to send samples to a laboratory and instead returns results in as little as 6 minutes when and where required.

The superiority of the VeraSTAT allows for users to overcome performance limitations of previous generation tests relating to sensitivity, accuracy, ease of use and cost efficiency. This, combined with a versatile test menu, means that the Randox VeraSTAT is built to outshine and enhance detection in any setting.

GET IN TOUCH

Click here to download Windows App:

  1. Download VeraSTAT Analyzer windows application to your computer.
  2. Extract the zipped file and double click VeraSTATsetup
  3. Follow the application install instruction to install the application on device
Download

VeraSTAT Test Menu

C-Reactive Protein (CRP)

CRP is the dominant acute phase protein often used to guide treatment of a bacterial infection or inflammation associated with tissue injury, inflammatory disorders and associated diseases.

Myxovirus Resistance Protein I (MxA)

An informative general marker for the most common acute viral infections. MxA protein has the potential to greatly enhance the rapid distinction between viral and bacterial respiratory infections.

Useful Resources

VERASTAT-V

GET IN TOUCH

VERASTAT BROCHURE


Request a meeting
×
Make an Enquiry - RX series
×
Make an Enquiry - Reagents
×
Kit Insert Request - Reagents
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
Kit Insert Request - Reagents
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
Make an Enquiry - Reagents
×
Make an Enquiry - Quality Control
×
Make an Enquiry - RIQAS
×
Make an Enquiry - RIQAS